PROFIT CONTROLS RATE OF RETURN
“UK model” and a few other countries in OECD 2000 Survey: Czech Republic, Spain, Korea, Mexico Turkey ?
Indirect effect on prices
Price control for generics, price cuts
Raises issues:
Ad Hoc ? Enforcement ? RD fixed costs ? Transparency ?
Tight control of the penetration rate for expensive drugs